.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Benazepril hydrochloride - Generic Drug Details

« Back to Dashboard
Benazepril hydrochloride is the generic ingredient in four branded drugs marketed by Sandoz, Teva, Aurobindo Pharma, Prinston Inc, Amneal Pharms Llc, Apotex Inc, Mylan, Ivax Sub Teva Pharms, Sun Pharm Inds Ltd, Zydus Pharms Usa, Us Pharms Holdings I, Actavis Labs Fl Inc, Genpharm, and Mylan Pharms Inc, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for benazepril hydrochloride. Forty-one suppliers are listed for this compound.

Summary for Generic Name: benazepril hydrochloride

Tradenames:4
Patents:0
Applicants:14
NDAs:21
Drug Master File Entries: see list14
Suppliers / Packagers: see list41
Bulk Api Vendors: see list47
Clinical Trials: see list994
Patent Applications: see list1,404
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:benazepril hydrochloride at DailyMed

Pharmacology for Ingredient: benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-001Jun 25, 1991RXYesNo► subscribe► subscribe
Apotex Inc
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL078794-002Aug 21, 2014RXNoNo► subscribe► subscribe
Actavis Labs Fl Inc
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076342-002Feb 11, 2004DISCNNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-001Jun 25, 19914,410,520*PED► subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-004Jun 25, 19914,410,520*PED► subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-002Jun 25, 19914,410,520*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc